Funding round
Inari Growth
Reported as "Growth Equity"
Inari, which works in seed design and breeding technology development in Cambridge, raised $144M in a Growth round announced on 7 Jan 2025. 5 firms took part. It is Inari's sixth venture round on record; the one before was a Growth in Jan 2024.
$144M
Amount raised
Not disclosed
Post-money valuation
5
Investors
no lead named
Valuation
What this round says about the price
Inari did not disclose a valuation in this round; its last disclosed one was $1.65B at the Growth (Jan 2024). It came 12 months after Inari's Growth. It is 20% of the $708M Inari has raised in the venture rounds on record. No later venture round is on record for Inari.
Inari's funding rounds
Inari has 6 venture rounds on record and 1 other deal. This one is highlighted.
- Series B 9 Aug 2018, led by Flagship Pioneering $40M
- Series C 6 Aug 2019 $89M
- Debt not a venture round 22 Apr 2020 $45M
- Series D 12 May 2021, led by Flagship Pioneering and Alexandria Venture Investments $208M$1.20B post-money
- Series E 4 Oct 2022, led by Canada Pension Plan Investment Board and Flagship Pioneering $124M$1.50B post-money
- Growth 30 Jan 2024 $103M$1.65B post-money
- Growth this round 7 Jan 2025 $144M
Investors
Who put money in
5 firms took part; no lead investor was named.
Investors
- Abu Dhabi Investment Authority backs 19 venture-backed companies new investor
- Hanwha Impact new investor
- NGS Super new investor
- State of Michigan Retirement System new investor
- Flagship Pioneering new investor
Use of proceeds
What the money is for
According to the announcement, the money goes to product development, scaling operations and working capital.
- Product development
- Scaling operations
- Working capital
Comparable rounds
How it compares
38 Growth rounds in Biotechnology within a year either side disclosed an amount; the median was $51M, and this round was 2.8 times the median. The closest in time, other companies' Growth rounds in Biotechnology:
| Company | Announced | Amount | Post-money | Led by |
|---|---|---|---|---|
| Biotechnology | 8 Jan 2025 | $200M | not disclosed | ARCH Venture Partners and F-Prime Capital |
| Biotechnology | 13 Jan 2025 | $165M | not disclosed | Rubicon Founders |
| Biotechnology | 14 Jan 2025 | $41M | not disclosed | Cathay Innovation |
| Biotechnology | 3 Feb 2025 | $185M | not disclosed | not named |
| Biotechnology | 11 Dec 2024 | $75M | not disclosed | Cormorant Asset Management and ARCH Venture Partners |
| Biotechnology | 10 Dec 2024 | $38M | not disclosed | Cathay Innovation |
| Isomorphic Labs Biotechnology | 31 Mar 2025 | $600M | not disclosed | Thrive Capital |
| Biotechnology | 11 Mar 2025 | $49M | not disclosed | not named |
Sources
Where this comes from
Reported by 2 sources.
Questions
Frequently asked
How much did Inari raise in its Growth round?
Inari raised $144M in its Growth round, announced in Jan 2025.
Which investors took part in Inari's Growth round?
Abu Dhabi Investment Authority, Hanwha Impact, NGS Super, State of Michigan Retirement System and Flagship Pioneering.
What was Inari's valuation at the Growth round?
It was not disclosed; its last disclosed one was $1.65B at the Growth (Jan 2024).
How does it compare with other Growth rounds in Biotechnology?
38 Growth rounds in Biotechnology within a year either side disclosed an amount; the median was $51M, and this round was 2.8 times the median.